|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 31/352 | (2006.01) | ||
| A61K 36/185 | (2006.01) | ||
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 3206715 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15784107.3 |
| Date of filing the European patent application | 2015-10-14 | |
| (97) | Date of publication of the European application | 2017-08-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/GB2015/053024 |
| Date | 2015-10-14 |
| (87) | Number | WO 2016/059399 |
| Date | 2016-04-21 |
| (30) | Number | Date | Country code |
| 201418170 | 2014-10-14 | GB |
| (72) |
GUY, Geoffrey, GB
WRIGHT, Stephen, GB
MEAD, Alice, GB
THIELE, Elizabeth, US
|
| (73) |
Jazz Pharmaceuticals Research UK Limited,
Building 730 Kent Science Park, Sittingbourne, Kent, ME9 8AG,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kanabidiolio naudojimas tuberozinės sklerozės komplekso gydymui |
| USE OF CANNABIDIOL IN THE TREATMENT OF TUBEROUS SCLEROSIS COMPLEX |
| Payment date | Validity (years) | Amount | |
| 2025-08-28 | 11 | 289.00 EUR |
| 2026-10-14 |